Adage Capital Management, L.P.

13D and 13G Filings

13D/G filings
13D on 2 securities, 13G on 147 securities
CIK
0001535978
All SEC filings
View on sec.gov
Issuer % of Class Filed
Forefront Tech Holdings Acquisition Corp 13G
FTHA · G3624C106
9.0% 8/12/2026
Event 6/30/2026
Equillium, Inc. 13G/A Amendment 1
EQ · 29446K106
7.3% 8/12/2026
Event 6/30/2026
Energy Transition Special Opportunities 13G
ETSS · G23017109
9.0% 8/12/2026
Event 6/30/2026
Cybin Inc. 13G
HELP · 23256X407
5.3% 8/12/2026
Event 6/30/2026
Yorkville International Capital Corp. 13G
G98665104
7.8% 8/12/2026
Event 6/30/2026
SCYNEXIS, Inc. 13G
SCYX · 811292309
10.0% 8/12/2026
Event 6/30/2026
XPLR Infrastructure, LP 13G
XIFR · 65341B106
6.6% 8/12/2026
Event 6/30/2026
Churchill Capital Corp XII 13G
CXII · G2131M102
6.5% 8/12/2026
Event 6/30/2026
SAB Biotherapeutics, Inc. 13G
SABS · 78397T202
8.4% 8/12/2026
Event 6/30/2026
RRE Ventures Acquisition Corp. 13G
RREV · G770AL103
9.0% 8/12/2026
Event 6/30/2026
West Enclave Merger Corp. 13G
WENC · G9600E107
5.6% 8/12/2026
Event 6/30/2026
Churchill Capital Corp XI 13G/A Amendment 1
CCXI · G2131A108
1.9% 8/12/2026
Event 6/30/2026
RMG ML Sports Holdings 13G
SHOT · G7610P104
8.2% 8/12/2026
Event 6/30/2026
Viking Acquisition Corp I 13G/A Amendment 1
VACI · G9582G104
6.0% 8/12/2026
Event 6/30/2026
CH4 Natural Solutions Corp 13G
MTNE · G2104X101
8.1% 8/12/2026
Event 6/30/2026
NextCure, Inc. 13G
NXTC · 65343E207
7.7% 8/12/2026
Event 6/30/2026
Texas Ventures Acquisition IV Corp 13G
TVIV · G8773A108
7.8% 8/12/2026
Event 6/30/2026
Centessa Pharmaceuticals plc 13G/A Amendment 4
CNTA · 152309100
0% 8/12/2026
Event 6/30/2026
NewHold Investment Corp IV 13G
NHIV · G6486G107
7.6% 8/12/2026
Event 6/30/2026
Tenax Therapeutics, Inc. 13G/A Amendment 1
TENX · 88032L605
6.8% 8/12/2026
Event 6/30/2026
Cabaletta Bio, Inc. 13G/A Amendment 7
CABA · 12674W109
8.4% 8/12/2026
Event 6/30/2026
Monro, Inc. 13G/A Amendment 1
MNRO · 610236101
3.2% 8/12/2026
Event 6/30/2026
Patriot Acquisition Corp. 13G
PTAC · G6951A106
8.2% 8/12/2026
Event 6/30/2026
Monopar Therapeutics Inc. 13G/A Amendment 2
MNPR · 61023L207
4.8% 8/12/2026
Event 6/30/2026
Bright Minds Biosciences Inc. 13G/A Amendment 1
DRUG · 10919W405
3.4% 8/12/2026
Event 6/30/2026
Oceanhawk Acquisition Corp. 13G
OHAC · G6722R107
5.7% 8/12/2026
Event 6/30/2026
Long Table Growth Corp. 13G
LTGR · G5701H106
7.8% 8/12/2026
Event 6/30/2026
Bleichroeder Acquisition Corp. II 13G/A Amendment 1
BBCQ · G1170E104
3.7% 8/12/2026
Event 6/30/2026
Karyopharm Therapeutics Inc. 13G/A Amendment 1
KPTI · 48576U205
6.8% 8/12/2026
Event 6/30/2026
KPET Ultra Paceline Corporation 13G
KPET · G53157106
7.8% 8/12/2026
Event 6/30/2026
Irenic Acquisition Corp. 13G
IACQ · G4939F107
7.6% 8/12/2026
Event 6/30/2026
Iron Dome Acquisition I Corp. 13G
IDAC · G4949K104
8.5% 8/12/2026
Event 6/30/2026
Aura Biosciences, Inc. 13G/A Amendment 4
AURA · 05153U107
8.4% 8/12/2026
Event 6/30/2026
Inovio Pharmaceuticals, Inc. 13G/A Amendment 2
INO · 45773H409
4.0% 8/12/2026
Event 6/30/2026
Inflection Point Acquisition Corp. VI 13G/A Amendment 1
IPFX · G4790S107
4.2% 8/12/2026
Event 6/30/2026
AmperCap Acquisition Company 13G
APMC · G0344N107
5.6% 8/12/2026
Event 6/30/2026
Gores Holdings XI, Inc. 13G
GHXIU · G40008123
7.8% 8/12/2026
Event 6/30/2026
EyePoint, Inc. 13G
EYPT · 30233G209
5.7% 8/12/2026
Event 6/30/2026
Tango Therapeutics, Inc. 13G/A Amendment 2
TNGX · 87583X109
3.4% 8/12/2026
Event 6/30/2026
General Catalyst Global Resilience Merger Corp. 13G
GCGR · G3793T104
7.7% 8/12/2026
Event 6/30/2026
ACP Holdings Acquisition Corp. 13G
ACGC · G0113G101
8.2% 8/12/2026
Event 6/30/2026
Snow Rothschild Acquisition Corp. 13G
ISNRU · G8251A125
8.0% 8/12/2026
Event 6/30/2026
Forte Biosciences, Inc. 13G/A Amendment 1
FBRX · 34962G208
3.4% 8/12/2026
Event 6/30/2026
Traws Pharma, Inc. 13G/A Amendment 1
TRAW · 68232V884
4.8% 8/12/2026
Event 6/30/2026
Nine Energy Service, Inc. 13G
NINE · 65441V200
9.7% 7/9/2026
Event 3/31/2026
X3 Acquisition Corp. Ltd. 13G
XCBE · G9831H101
8.0% 5/13/2026
Event 3/31/2026
Willow Lane Acquisition Corp. II 13G
WLII · G9675K103
6.7% 5/13/2026
Event 3/31/2026
TRG Latin America Acquisitions Corp. 13G
TRGS · G9037S109
8.6% 5/13/2026
Event 3/31/2026
SUMA Acquisition Corporation 13G
SUMA · G8557R103
7.6% 5/13/2026
Event 3/31/2026
Spring Valley Acquisition Corp. IV 13G
SVIV · G8377G105
7.8% 5/13/2026
Event 3/31/2026
Spartacus Acquisition Corp. II 13G
TMTSU · G8303R126
7.8% 5/13/2026
Event 3/31/2026
Space Asset Acquisition Corp. 13G
SAAQ · G8375S101
7.6% 5/13/2026
Event 3/31/2026
Soren Acquisition Corp. 13G
SORN · G8274J103
7.5% 5/13/2026
Event 3/31/2026
QDRO Acquisition Corp. 13G
QADRU · G7310E128
7.5% 5/13/2026
Event 3/31/2026
Presidio Production Company 13G
FTW · G3106N109
10.0% 5/13/2026
Event 3/31/2026
Paloma Acquisition Corp I 13G
PALO · G6881J102
8.0% 5/13/2026
Event 3/31/2026
Opus Genetics, Inc. 13G
IRD · 67577R102
8.5% 5/13/2026
Event 3/31/2026
OneIM Acquisition Corp. 13G
OIM · G6S74K106
7.8% 5/13/2026
Event 3/31/2026
Muzero Acquisition Corp 13G
MUZE · G8775A106
7.6% 5/13/2026
Event 3/31/2026
Mountain Lake Acquisition Corp. II 13G
MLAA · G6301L109
5.7% 5/13/2026
Event 3/31/2026
Monro, Inc. 13G
MNRO · 610236101
5.2% 5/13/2026
Event 3/31/2026
Metals Acquisition Corp. II 13G
MTAL · G60420109
7.8% 5/13/2026
Event 3/31/2026
M Evo Global Acquisition Corp II 13G
MEVO · G6071J102
8.1% 5/13/2026
Event 3/31/2026
Legato Merger Corp. IV 13G
LEGO · G7318R105
5.8% 5/13/2026
Event 3/31/2026
KRAKacquisition Corp 13G
KRAQ · G5315G106
7.2% 5/13/2026
Event 3/31/2026
Karyopharm Therapeutics Inc. 13G
KPTI · 48576U205
8.1% 5/13/2026
Event 3/31/2026
Iris Acquisition Corp II 13G
IRAB · G4940M109
7.8% 5/13/2026
Event 3/31/2026
Wave Life Sciences Ltd. 13G/A Amendment 6
WVE · Y95308105
0.5% 5/13/2026
Event 3/31/2026
Infinite Eagle Acquisition Corp. 13G
IEAG · G4802J103
6.5% 5/13/2026
Event 3/31/2026
Inflection Point Acquisition Corp. VI 13G
IPFXU · G4790S123
5.9% 5/13/2026
Event 3/31/2026
Terns Pharmaceuticals, Inc. 13G/A Amendment 1
TERN · 880881107
1.8% 5/13/2026
Event 3/31/2026
Tango Therapeutics, Inc. 13G/A Amendment 1
TNGX · 87583X109
9.0% 5/13/2026
Event 3/31/2026
Hennessy Capital Investment Corp. VIII 13G
HCIC · G44055104
7.6% 5/13/2026
Event 3/31/2026
Seadrill Ltd 13G/A Amendment 3
SDRL · G7997W102
3.9% 5/13/2026
Event 3/31/2026
Fortress Value Acquisition Corp. V 13G
FVAV · G3645T104
7.8% 5/13/2026
Event 3/31/2026
Relmada Therapeutics, Inc. 13G/A Amendment 1
RLMD · 75955J402
4.5% 5/13/2026
Event 3/31/2026
Northpointe Bancshares, Inc. 13G/A Amendment 1
NPB · 66661N886
7.5% 5/13/2026
Event 3/31/2026
Forte Biosciences, Inc. 13G
FBRX · 34962G208
6.8% 5/13/2026
Event 3/31/2026
FG Imperii Acquisition Corp. 13G
FGII · G3R41C102
7.8% 5/13/2026
Event 3/31/2026
Nabors Industries Ltd. 13G/A Amendment 1
NBR · G6359F137
4.7% 5/13/2026
Event 3/31/2026
Columbus Circle Capital Corp II 13G
IPXG · G2296M103
7.6% 5/13/2026
Event 3/31/2026
Cambridge Acquisition Corp. 13G
CAQ · G1871M108
7.7% 5/13/2026
Event 3/31/2026
Monopar Therapeutics 13G/A Amendment 1
MNPR · 61023L207
6.2% 5/13/2026
Event 3/31/2026
Blue Water Acquisition Corp. IV 13G
BWIVU · G1368A120
8.4% 5/13/2026
Event 3/31/2026
Milestone Pharmaceuticals Inc. 13G/A Amendment 1
MIST · 59935V107
6.4% 5/13/2026
Event 3/31/2026
Metropolitan Bank Holding Corp. 13G/A Amendment 1
MCB · 591774104
4.8% 5/13/2026
Event 3/31/2026
Bleichroeder Acquisition Corp. II 13G
BBCQ · G1170E104
7.8% 5/13/2026
Event 3/31/2026
MeiraGTx Holdings plc 13G/A Amendment 6
MGTX · G59665102
4.9% 5/13/2026
Event 3/31/2026
Averin Capital Acquisition Corp. 13G
ACAA · G0679A100
8.9% 5/13/2026
Event 3/31/2026
Inovio Pharmaceuticals, Inc. 13G/A Amendment 1
INO · 45773H409
5.8% 5/13/2026
Event 3/31/2026
Atara Biotherapeutics, Inc. 13G
ATRA · 046513206
8.6% 5/13/2026
Event 3/31/2026
Heron Therapeutics, Inc. 13G/A Amendment 1
HRTX · 427746102
0% 5/13/2026
Event 3/31/2026
Armada Acquisition Corp. III 13G
AACI · G0R38M101
7.9% 5/13/2026
Event 3/31/2026
EyePoint, Inc. 13G/A Amendment 7
EYPT · 30233G209
4.0% 5/13/2026
Event 3/31/2026
Archimedes Tech SPAC Partners III Co. 13G
ARCI · G0453R105
5.1% 5/13/2026
Event 3/31/2026
DBV Technologies S.A. 13G/A Amendment 1
DBVT · 23306J309
7.3% 5/13/2026
Event 3/31/2026
Aldabra 4 Liquidity Opportunity Vehicle, Inc. 13G
ALOV · G01900102
5.8% 5/13/2026
Event 3/31/2026
Centessa Pharmaceuticals plc 13G/A Amendment 3
CNTA · 152309100
5.8% 5/13/2026
Event 3/31/2026
Adagio Medical Holdings, Inc. 13G/A Amendment 2
ADGM · 00534B100
5.7% 5/13/2026
Event 3/31/2026
Abony Acquisition Corp. I 13G
AACO · G00582109
7.6% 5/13/2026
Event 3/31/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.